Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?
Abnormal metabolism is a key tumor hallmark. Proton magnetic resonance spectroscopy (1H-MRS) allows measurement of metabolite concentration that can be utilized to characterize tumor metabolic changes. 1H-MRS measurements of specific metabolites have been implemented in the clinic. This article perf...
| Publicado en: | Diagnostic & Interventional Radiology Vol. 22; no. 1; pp. 75 - 90 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | diagnostic images pictorial review tables/charts Journal Article |
| Publicado: |
Galenos Yayinevi Tic. LTD. STI
Jan2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Abnormal metabolism is a key tumor hallmark. Proton magnetic resonance spectroscopy (1H-MRS) allows measurement of metabolite concentration that can be utilized to characterize tumor metabolic changes. 1H-MRS measurements of specific metabolites have been implemented in the clinic. This article performs a systematic review of image acquisition and interpretation of 1H-MRS for cancer evaluation, evaluates its strengths and limitations, and correlates metabolite peaks at 1H-MRS with diagnostic and prognostic parameters of cancer in different tumor types. |
|---|